Abstract
A case of central venous catheter-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myelogenous leukaemia is reported. The patient was successfully treated with amikacin and piperacillin-tazobactam. The clinical isolate was identified as R. mucosa by 16S rRNA gene sequencing.
MeSH terms
-
Acute Disease
-
Adult
-
Amikacin / therapeutic use
-
Anti-Bacterial Agents / therapeutic use
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / therapeutic use
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use
-
Bacteremia / drug therapy
-
Bacteremia / etiology*
-
Base Sequence
-
Catheterization, Central Venous / adverse effects*
-
Cytarabine / administration & dosage
-
Cytarabine / therapeutic use
-
Humans
-
Leukemia, Myeloid / complications*
-
Leukemia, Myeloid / drug therapy
-
Male
-
Methylobacteriaceae / classification
-
Methylobacteriaceae / genetics
-
Methylobacteriaceae / isolation & purification*
-
Molecular Sequence Data
-
Neutropenia / complications*
-
Penicillanic Acid / analogs & derivatives
-
Penicillanic Acid / therapeutic use
-
Phylogeny
-
Piperacillin / therapeutic use
-
Piperacillin, Tazobactam Drug Combination
-
RNA, Bacterial
-
RNA, Ribosomal, 16S / genetics
-
Vidarabine / analogs & derivatives
-
Vidarabine / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
RNA, Bacterial
-
RNA, Ribosomal, 16S
-
Cytarabine
-
Piperacillin, Tazobactam Drug Combination
-
Amikacin
-
Penicillanic Acid
-
Vidarabine
-
fludarabine
-
Piperacillin